90 related articles for article (PubMed ID: 6212068)
1. [Course of hypertension and the potentials for regression].
Shkhvatsabaia IK
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):5-12. PubMed ID: 6212068
[No Abstract] [Full Text] [Related]
2. [Calcium antagonists].
Littler WA
Cardiologia; 1984; 29(1-2):121-7. PubMed ID: 6398704
[No Abstract] [Full Text] [Related]
3. Relationship between regression of cardiovascular hypertrophy and rate of redevelopment of hypertension.
Korner PI; Jennings GL; Esler MD
J Clin Hypertens; 1987 Sep; 3(3):341-8. PubMed ID: 2959758
[No Abstract] [Full Text] [Related]
4. Importance of blood pressure variability in organ protection in spontaneously hypertensive rats treated with combination of nitrendipine and atenolol.
Xie HH; Miao CY; Liu JG; Su DF
Acta Pharmacol Sin; 2002 Dec; 23(12):1199-204. PubMed ID: 12466061
[TBL] [Abstract][Full Text] [Related]
5. Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients.
Schiffrin EL; Deng LY; Larochelle P
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S51-6. PubMed ID: 7700067
[TBL] [Abstract][Full Text] [Related]
6. Comparison of hypotensive and hypolipidemic effects of Catharanthus roseus leaves extract with atenolol on adrenaline induced hypertensive rats.
Ara N; Rashid M; Amran MS
Pak J Pharm Sci; 2009 Jul; 22(3):267-71. PubMed ID: 19553172
[TBL] [Abstract][Full Text] [Related]
7. [Hemodynamic mechanism of the hypotensive action of diuretics and their effect on myocardial hypertrophy in the process of long-term treatment of hypertension].
D'iakonova EG; Iurenev AP
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):57-61. PubMed ID: 6212070
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension.
Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Castellano M; Cavaliere G; Nordio G; Pasini F; Zuccato F
J Cardiovasc Pharmacol; 1994; 24 Suppl A():S37-43. PubMed ID: 7603076
[TBL] [Abstract][Full Text] [Related]
10. Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.
Gottdiener JS
Circulation; 1999 Aug; 100(6):685-6. PubMed ID: 10490345
[No Abstract] [Full Text] [Related]
11. Vascular adaptation to long-term blood pressure reduction.
Werkö L
Acta Med Scand; 1980; 207(6):207. PubMed ID: 7435236
[No Abstract] [Full Text] [Related]
12. Cerebral blood flow autoregulation in hypertension and effects of antihypertensive drugs.
Barry DI; Lassen NA
J Hypertens Suppl; 1984 Dec; 2(3):S519-26. PubMed ID: 6400382
[TBL] [Abstract][Full Text] [Related]
13. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
14. Regression of left ventricular hypertrophy and control of hypertension in the spontaneously hypertensive rat (SHR): oxprenolol versus hydrochlorothiazide.
Idikio H; Fernandez PG; Triggle CR; Kim BK
Clin Invest Med; 1983; 6(1):43-8. PubMed ID: 6219850
[TBL] [Abstract][Full Text] [Related]
15. [New approaches in choosing the therapy of patients with hypertension].
Ol'binskaia LI; Stiazhkin VIu; Iamshchikov SN
Ter Arkh; 1989; 61(9):24-9. PubMed ID: 2531936
[No Abstract] [Full Text] [Related]
16. Cardiac morphology and function in arterial hypertension. The effects of a new multifactorial hypotensive agent: urapidil.
Ghione S; Genovesi-Ebert A; Marabotti C; Spinazzi A; Noseda A
Blood Press Suppl; 1994; 4():25-30. PubMed ID: 7804509
[TBL] [Abstract][Full Text] [Related]
17. [To protect the hypertensive patient from complications. Blood pressure lowering is not equal to blood pressure lowering].
MMW Fortschr Med; 2003 Nov; 145(45):51. PubMed ID: 14712789
[No Abstract] [Full Text] [Related]
18. Thyroxine cardiomegaly in rats is not hypertension-bound.
Schreiber V; Kapitola J; Kölbel F
Physiol Bohemoslov; 1985; 34(2):97-101. PubMed ID: 3161111
[TBL] [Abstract][Full Text] [Related]
19. Resistant hypertension: Core Curriculum 2008.
Parker MG
Am J Kidney Dis; 2008 Oct; 52(4):796-802. PubMed ID: 18706748
[No Abstract] [Full Text] [Related]
20. Serial hemodynamic measurements allow better blood pressure control than clinical judgment in those with refractory hypertension.
Basile J
J Clin Hypertens (Greenwich); 2002; 4(6):434-5. PubMed ID: 12461310
[No Abstract] [Full Text] [Related]
[Next] [New Search]
